Study to assess the effect of AZD4831 on the pharmacokinetics (drug behavior in the body) of Midazolam

Trial Identifier:	D6580C00012
Sponsor:	AstraZeneca
NCTID::	NCT05052710
Start Date:	October 2021
Primary Completion Date:	November 2021
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	Harrow, United Kingdom, HA1 3UJ

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.